CMPX - Compass Therapeutics

-

$undefined

N/A

(N/A)

Compass Therapeutics NASDAQ:CMPX

Location: | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

81.8M

Cash

126.7M

Avg Qtr Burn

-11.21M

Short % of Float

5.51%

Insider Ownership

18.08%

Institutional Own.

70.96%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2/3

Data readout

Phase 2

Initiation

CTX-471 +/- KEYTRUDA® (pembrolizumab) Details
Cancer, Small cell lung cancer, Non-small cell lung carcinoma, Melanoma

Phase 2

Initiation

Phase 1

Data readout

IND

Submission